{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:17Z","timestamp":1790700137997,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010900","name":"Yale Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clml.2019.12.027","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T19:34:13Z","timestamp":1579289653000},"page":"244-251.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-9946","authenticated-orcid":false,"given":"Julie Kay","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shank-Coviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"McCorkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sarpong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Medoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5168-8325","authenticated-orcid":false,"given":"Stuart","family":"Seropian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.12.027_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbmt.2017.05.035","article-title":"Current use and trends in hematopoietic cell transplantation in the United States","volume":"9","author":"D\u2019Souza","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentifical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0609.2002.01661.x","article-title":"Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high dose cyclophosphamide","volume":"69","author":"Auner","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2019.12.027_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20904","article-title":"Melphalan-induced supraventricular tachycardia: incidence and risk factors","volume":"34","author":"Feliz","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clml.2019.12.027_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.bmt.1704623","article-title":"Supraventricular tachyarrhythmias after hematopoietic stem cell Transplantation: incidence, risk factors and outcomes","volume":"34","author":"Hidalgo","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.20042","article-title":"Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation","volume":"76","author":"Nakamae","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2019.12.027_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1704487","article-title":"Predictors for severe cardiac complications after hematopoietic stem cell transplantation","volume":"33","author":"Sakata-Yanagimoto","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bmt.1702507","article-title":"Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide","volume":"26","author":"Snowden","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib12","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.transproceed.2007.11.077","article-title":"Cardiac systolic function in patients receiving hematopoietic stem cell transplantation: risk factors for posttransplantation cardiac toxicity","volume":"40","author":"Sucak","year":"2008","journal-title":"Transplant Proceed"},{"key":"10.1016\/j.clml.2019.12.027_bib13","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","article-title":"Arrhythmias in the setting of hematopoietic cell transplants","volume":"50","author":"Tonorezos","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib14","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.12.027_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/hrt.2007.123299","article-title":"Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function","volume":"94","author":"Chung","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.clml.2019.12.027_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2014.926346","article-title":"Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma","volume":"56","author":"Gul","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2019.12.027_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2013.05.019","article-title":"Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation","volume":"19","author":"Singla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/1753944712464102","article-title":"Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors","volume":"6","author":"Sureddi","year":"2012","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.clml.2019.12.027_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bmt.1701609","article-title":"Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases","volume":"23","author":"Alessandrino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib20","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2015.60.8125","article-title":"Heart failure and asymptomatic left ventricular systolic dysfunction in lymphoma: survivors treated with autologous stem-cell transplantation: a national cross-sectional study","volume":"33","author":"Murbraech","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2019.12.027_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.bmt.1703890","article-title":"Electrocardiogram is very useful for predicting acute heart failure following myeloablative chemotherapy with hematopoietic stem cell transplantation rescue","volume":"31","author":"Akohori","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bjh.13357","article-title":"Risk factors for pericardial effusion in adult patients receiving allogeneic haematopoietic stem cell transplantation","volume":"169","author":"Liu","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2019.12.027_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-9966-31-13","article-title":"Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Roziakova","year":"2012","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.clml.2019.12.027_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","article-title":"Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"45","author":"Peres","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2009.06.001","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction","volume":"15","author":"Qazilbash","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib27","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.12.027_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bmt.1701734","article-title":"Predictive value of left ventricular ejection fraction in stem cell transplantation","volume":"23","author":"Zangari","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0272-6386(03)00372-X","article-title":"Cardiac complications in chronic kidney disease","volume":"41","author":"Sarnak","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clml.2019.12.027_bib30","first-page":"99","article-title":"The link between chronic kidney disease and cardiovascular disease","volume":"3","author":"Said","year":"2014","journal-title":"J\u00a0Nephropathol"},{"key":"10.1016\/j.clml.2019.12.027_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","article-title":"Linking heart failure to cancer: background evidence and research perspectives","volume":"138","author":"Bertero","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clml.2019.12.027_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2019.12.027_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.117.312115","article-title":"Somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease","volume":"122","author":"Fuster","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.clml.2019.12.027_bib34","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/bmt.2015.64","article-title":"Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center","volume":"50","author":"Miller","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00280-014-2657-8","article-title":"Prevalence and clinical significance of potential drug-drug interaction in hematopoietic stem cell transplantation","volume":"75","author":"Trevisan","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clml.2019.12.027_bib36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/hrt.63.6.342","article-title":"QT dispersion: an indication of arrhythmia risk in patients with long QT intervals","volume":"63","author":"Day","year":"1990","journal-title":"Br Heart J"},{"key":"10.1016\/j.clml.2019.12.027_bib37","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"Bosch","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2019.12.027_bib38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.2217\/fon.15.139","article-title":"Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers","volume":"11","author":"Akhter","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.clml.2019.12.027_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11906-010-0146-y","article-title":"Mechanisms of anthracycline cardiotoxicity and strategies to decrease cardiac damage","volume":"12","author":"Geisberg","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.clml.2019.12.027_bib40","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.jacc.2018.02.064","article-title":"Global longitudinal strain to predict mortality in patients with acute heart failure","volume":"71","author":"Park","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2019.12.027_bib41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1701217","article-title":"Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells","volume":"21","author":"Olivieri","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2019.12.027_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","article-title":"Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation","volume":"155","author":"Chow","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2019.12.027_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","article-title":"Cardiovascular disease after cancer therapy","volume":"12","author":"Aleman","year":"2014","journal-title":"EJC Suppl"},{"key":"10.1016\/j.clml.2019.12.027_bib44","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clml.2019.12.027_bib45","doi-asserted-by":"crossref","first-page":"1465.e11","DOI":"10.1016\/j.amjmed.2017.07.020","article-title":"Low albumin levels are associated with mortality risk in hospitalized patients","volume":"130","author":"Akirov","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.clml.2019.12.027_bib46","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2018.02.049","article-title":"Carvedilol for prevention of chemotherapy-related cardiotoxicity","volume":"71","author":"Avila","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clml.2019.12.027_bib47","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1118\/1.1509442","article-title":"Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications","volume":"29","author":"Basavaraju","year":"2002","journal-title":"Med Phys"},{"key":"10.1016\/j.clml.2019.12.027_bib48","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S1470-2045(18)30457-1","article-title":"Immune checkpoint inhibitors and cardiovascular toxicity","volume":"19","author":"Lyon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2019.12.027_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.clml.2019.12.027_bib50","first-page":"160","article-title":"Cardiovascular and cancer risk: the role of cardio-oncology","volume":"9","author":"Coviello","year":"2018","journal-title":"J\u00a0Adv Pract Oncol"},{"key":"10.1016\/j.clml.2019.12.027_bib51","author":"Simprini"},{"key":"10.1016\/j.clml.2019.12.027_bib52","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.clml.2019.12.027_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020300124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:33:43Z","timestamp":1761870823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020300124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2152265020300124"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.12.027","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}